Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy Sep. 20, 2019 No Comments
Phase III AMPLIFY study of phosphate absorption inhibitor tenapanor meets primary endpoint Sep. 4, 2019 No Comments
RSS